AVIR
Price
$4.04
Change
-$0.01 (-0.25%)
Updated
Oct 23 closing price
Capitalization
324.03M
18 days until earnings call
Intraday BUY SELL Signals
CELC
Price
$65.25
Change
-$0.32 (-0.49%)
Updated
Oct 23 closing price
Capitalization
3.19B
17 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AVIR vs CELC

AVIR vs CELC Comparison Chart in %
View a ticker or compare two or three
VS
AVIR vs. CELC commentary
Oct 25, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVIR is a StrongBuy and CELC is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for AVIR with price predictions
Oct 23, 2026

AVIR's RSI Oscillator stays in oversold zone for 7 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +3.36% 3-day Advance, the price is estimated to grow further. Considering data from situations where AVIR advanced for three days, in 196 of 257 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

AVIR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AVIR as a result. In 69 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 77%.

AVIR moved below its 50-day moving average on October 01, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for AVIR crossed bearishly below the 50-day moving average on October 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 71%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVIR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.

The Aroon Indicator for AVIR entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 24 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 41 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.587) is normal, around the industry mean (3.043). P/E Ratio (-1.942) is within average values for comparable stocks, (-1.361). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (133.535) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating steady price growth. AVIR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVIR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for CELC with price predictions
Oct 23, 2026

CELC's RSI Oscillator ascending out of oversold territory

The RSI Indicator for CELC moved out of oversold territory on October 20, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 23 similar instances when the indicator left oversold territory. In 21 of the 23 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for CELC just turned positive on October 22, 2026. Looking at past instances where CELC's MACD turned positive, the stock continued to rise in 42 of 50 cases over the following month. The odds of a continued upward trend are 84%.

Following a +9.28% 3-day Advance, the price is estimated to grow further. Considering data from situations where CELC advanced for three days, in 249 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

CELC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CELC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

The Aroon Indicator for CELC entered a downward trend on October 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CELC's P/B Ratio (-249.809) is very low in comparison to the industry average of (3.035). P/E Ratio (-15.174) is within average values for comparable stocks, (-1.360). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (133.535) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron PE Growth Rating for this company is 19 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 65 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 79 (best 1 - 100 worst), indicating slightly worse than average price growth. CELC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
AVIR vs CELC: Fundamental Ratings
AVIR
CELC
OUTLOOK RATING
1..100
6850
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
1
Undervalued
PROFIT vs RISK RATING
1..100
10065
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
6479
P/E GROWTH RATING
1..100
2419
SEASONALITY SCORE
1..100
9085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CELC's Valuation (1) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for AVIR (41) in the Biotechnology industry. This means that CELC’s stock grew somewhat faster than AVIR’s over the last 12 months.

CELC's Profit vs Risk Rating (65) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for AVIR (100) in the Biotechnology industry. This means that CELC’s stock grew somewhat faster than AVIR’s over the last 12 months.

AVIR's SMR Rating (98) in the Biotechnology industry is in the same range as CELC (100) in the Miscellaneous Commercial Services industry. This means that AVIR’s stock grew similarly to CELC’s over the last 12 months.

AVIR's Price Growth Rating (64) in the Biotechnology industry is in the same range as CELC (79) in the Miscellaneous Commercial Services industry. This means that AVIR’s stock grew similarly to CELC’s over the last 12 months.

CELC's P/E Growth Rating (19) in the Miscellaneous Commercial Services industry is in the same range as AVIR (24) in the Biotechnology industry. This means that CELC’s stock grew similarly to AVIR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVIRCELC
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
N/A
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 11 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
84%
COMPARISON
Comparison
Oct 25, 2026
Stock price -- (AVIR: $4.04 vs. CELC: $65.25)
Brand notoriety: AVIR and CELC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVIR: 88% vs. CELC: 115%
Market capitalization -- AVIR: $324.03M vs. CELC: $3.19B
AVIR [@Biotechnology] is valued at $324.03M. CELC’s [@Biotechnology] market capitalization is $3.19B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $132.8B. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVIR’s FA Score shows that 1 FA rating(s) are green while CELC’s FA Score has 2 green FA rating(s).

  • AVIR’s FA Score: 1 green, 4 red.
  • CELC’s FA Score: 2 green, 3 red.
According to our system of comparison, both AVIR and CELC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVIR’s TA Score shows that 4 TA indicator(s) are bullish while CELC’s TA Score has 4 bullish TA indicator(s).

  • AVIR’s TA Score: 4 bullish, 5 bearish.
  • CELC’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, CELC is a better buy in the short-term than AVIR.

Price Growth

AVIR (@Biotechnology) experienced а -6.48% price change this week, while CELC (@Biotechnology) price change was +15.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was -16.30%, and the average quarterly price growth was -16.78%.

Reported Earning Dates

AVIR is expected to report earnings on Nov 11, 2026.

CELC is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (+1.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
AVIR
Daily Signal:
Gain/Loss:
CELC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ZMAR28.72N/A
N/A
Innovator 1 Yr March (ZMAR)
NHYB23.89N/A
N/A
Nuveen High Yield Corporate Bond ETF (NHYB)
FOPC24.64-0.01
-0.03%
Frontier Asset Opportunistic Credit ETF
DINE24.48-0.02
-0.06%
Simplify Tax Aware Diversified Income Strategy ETF (DINE)
PTMC39.25-0.24
-0.61%
Pacer Trendpilot US Mid Cap ETF (PTMC)

AVIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVIR has been loosely correlated with AXON. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if AVIR jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVIR
1D Price
Change %
AVIR100%
-0.25%
AXON - AVIR
46%
Loosely correlated
+1.39%
KRRO - AVIR
37%
Loosely correlated
-0.58%
VCYT - AVIR
36%
Loosely correlated
+4.11%
AMRN - AVIR
35%
Loosely correlated
+1.64%
MIST - AVIR
34%
Loosely correlated
-7.76%
More